Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association.

Kiernan TJ, Yan BP, Cubeddu RJ, Rengifo-Moreno P, Gupta V, Inglessis I, Ning M, Demirjian ZN, Jaff MR, Buonanno FS, Schainfeld RM, Palacios IF.

Stroke. 2009 Apr;40(4):1502-4. doi: 10.1161/STROKEAHA.108.527366. Epub 2009 Jan 29.

2.

Use of Magnetic Resonance Venography in Screening Patients With Cryptogenic Stroke for May-Thurner Syndrome.

Prabhakar AM, Misono AS, Brinegar KN, Khademhosseini A, Oklu R.

Curr Probl Diagn Radiol. 2016 Nov - Dec;45(6):370-372. doi: 10.1067/j.cpradiol.2016.04.006. Epub 2016 Apr 27.

PMID:
27338307
3.

Prevalence of Pelvic Vein Pathology in Patients with Cryptogenic Stroke and Patent Foramen Ovale Undergoing MRV Pelvis.

Osgood M, Budman E, Carandang R, Goddeau RP Jr, Henninger N.

Cerebrovasc Dis. 2015;39(3-4):216-23. doi: 10.1159/000376613. Epub 2015 Mar 14.

4.

Magnetic resonance venography in the diagnosis and management of May-Thurner syndrome.

Wolpert LM, Rahmani O, Stein B, Gallagher JJ, Drezner AD.

Vasc Endovascular Surg. 2002 Jan-Feb;36(1):51-7.

PMID:
12704525
5.

Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale.

Liberman AL, Daruwalla VJ, Collins JD, Maas MB, Botelho MP, Ayache JB, Carr J, Ruff I, Bernstein RA, Alberts MJ, Prabhakaran S.

Stroke. 2014 Aug;45(8):2324-9. doi: 10.1161/STROKEAHA.114.005539. Epub 2014 Jun 17.

6.

Prevalence of patent foramen ovale determined by transesophageal echocardiography in patients with cryptogenic stroke aged 55 years or older. Same as younger patients?

Mesa D, Ruiz M, Delgado M, Suárez de Lezo J, Pan M, Tejero I, García D, Crespín M, León C, Toledano F, Mazuelos F, Ochoa JJ, Bescansa E.

Rev Esp Cardiol. 2010 Mar;63(3):315-22. English, Spanish.

7.

Patent foramen ovale and cryptogenic stroke in older patients.

Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A.

N Engl J Med. 2007 Nov 29;357(22):2262-8.

8.

Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.

Bonvini RF, Sztajzel R, Dorsaz PA, Righini M, Bonvin C, Alibegovic J, Sigwart U, Camenzind E, Verin V, Sztajzel J.

Int J Stroke. 2010 Feb;5(1):4-9. doi: 10.1111/j.1747-4949.2009.00336.x.

PMID:
20088986
9.

Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study.

Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP.

Stroke. 1994 Mar;25(3):582-6.

PMID:
8128511
10.

Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.

Ford MA, Reeder GS, Lennon RJ, Brown RD, Petty GW, Cabalka AK, Cetta F, Hagler DJ.

JACC Cardiovasc Interv. 2009 May;2(5):404-11. doi: 10.1016/j.jcin.2008.12.015.

11.

Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.

Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guérin F, Bousser MG, de Recondo J.

Stroke. 1993 Dec;24(12):1865-73.

12.

Patent foramen ovale as a risk factor for cryptogenic stroke.

Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S.

Ann Intern Med. 1992 Sep 15;117(6):461-5.

PMID:
1503349
13.

Sex differences in cryptogenic stroke with patent foramen ovale.

Nedeltchev K, Wiedmer S, Schwerzmann M, Windecker S, Haefeli T, Meier B, Mattle HP, Arnold M.

Am Heart J. 2008 Sep;156(3):461-5. doi: 10.1016/j.ahj.2008.04.018. Epub 2008 Jul 2.

PMID:
18760126
14.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

15.

Prevention of stroke in patients with patent foramen ovale.

Mattle HP, Meier B, Nedeltchev K.

Int J Stroke. 2010 Apr;5(2):92-102. doi: 10.1111/j.1747-4949.2010.00413.x. Review.

PMID:
20446943
16.

Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.

Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM.

Circ Cardiovasc Imaging. 2014 Jan;7(1):125-31. doi: 10.1161/CIRCIMAGING.113.000807. Epub 2013 Nov 8.

17.

High frequency of silent pulmonary embolism in patients with cryptogenic stroke and patent foramen ovale.

Tanislav C, Puille M, Pabst W, Reichenberger F, Grebe M, Nedelmann M, Kaps M, Allendörfer J.

Stroke. 2011 Mar;42(3):822-4. doi: 10.1161/STROKEAHA.110.601575. Epub 2011 Jan 21.

18.

Patent foramen ovale and cryptogenic stroke: the hole story.

Furlan AJ, Jauss M.

Stroke. 2013 Sep;44(9):2676-8. doi: 10.1161/STROKEAHA.113.001676. Epub 2013 Aug 1.

19.

Microembolic signals in patients with cryptogenic stroke with or without patent foramen ovale.

Shariat A, Yaghoubi E, Nemati R, Moaref AR, Aghasadeghi K, Borhani Haghighi A.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):662-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.02.015. Epub 2011 Apr 3.

PMID:
21459615
20.

Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.

Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R.

Int J Cardiol. 2005 May 11;101(1):77-82.

PMID:
15860387

Supplemental Content

Support Center